Growing community of inventors

Larchmont, NY, United States of America

Lloyd A Greene

Average Co-Inventor Count = 2.14

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 49

Lloyd A GreeneJames Angelastro (8 patents)Lloyd A GreeneStephen E Farinelli (2 patents)Lloyd A GreeneDavid S Park (1 patent)Lloyd A GreeneXiaotian Sun (1 patent)Lloyd A GreeneLloyd A Greene (10 patents)James AngelastroJames Angelastro (8 patents)Stephen E FarinelliStephen E Farinelli (2 patents)David S ParkDavid S Park (1 patent)Xiaotian SunXiaotian Sun (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Columbia University (10 from 2,488 patents)

2. University of California (6 from 15,471 patents)


10 patents:

1. 12428455 - Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells

2. 11555057 - Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

3. 10273274 - Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

4. 10155796 - Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

5. 9758555 - Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

6. 9758556 - Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

7. 8158420 - Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5

8. 7888326 - Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5

9. 6087366 - Use of flavopiridol or a pharmaceutically acceptable salt thereof for

10. 5846984 - Use of ciclopirox or a pharmaceutically acceptable salt thereof for

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…